1. Steinman HM: Superoxide Dismutases: Protein chemistry and structure function relationships. In W Oberley (ed.). Superoxide dismutase. Vol. 1. CRC Press, Boca Raton, Florida: 11?68, 1982
2. Flohé L: Die unerwunschte Sauerstoffaktivierung dokumentiert am Beispiel bestimmter Entzündungen: der Weg zur Anwendung der Superoxiddismutase. In EF Elstner, W Bors, W Wilmanns (eds). Reaktive Sauerstoffspezies in der Medizin. Springer-Verlag, Berlin: 16?21, 1986
3. Huber W, Saifer MGP: Orgotein, the drug version of bovine Cu/Zn superoxide dismutase: I. A summary account of safety and pharmacology in laboratory animals. In AM Michelson, JM McCord, I Fridovich (eds). Superoxide and Superoxide Dismutases. Academic Press, London - New York - San Francisco: 517?536, 1977
4. McCord JM, Fridovich I: Superoxide dismutase: an enzymatic function for erythrocuprein (hemocuprein). J Biol Chem 244:6049?6055, 1969
5. Lund-Olesen K, Menander KB: Orgotein: a new antiinflammatory metalloprotein drug: preliminary evaluation of clinical efficacy and safety in degenerative joint disease. Curr Ther Res 16:706?717, 1974